News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,439 Results
Type
Article (49058)
Company Profile (308)
Press Release (671073)
Section
Business (211965)
Career Advice (2076)
Deals (36475)
Drug Delivery (92)
Drug Development (83341)
Employer Resources (169)
FDA (16886)
Job Trends (15659)
News (358571)
Policy (34589)
Tag
Academia (2758)
Alliances (51210)
Alzheimer's disease (1266)
Approvals (16798)
Artificial intelligence (126)
Bankruptcy (364)
Best Places to Work (11917)
Biotechnology (212)
Breast cancer (110)
Cancer (930)
Cardiovascular disease (85)
Career advice (1742)
Cell therapy (200)
Clinical research (65798)
Collaboration (331)
Compensation (168)
COVID-19 (2648)
Data (861)
Diabetes (137)
Diagnostics (6304)
Drug pricing (82)
Earnings (86218)
Employer resources (147)
Events (113699)
Executive appointments (248)
FDA (17333)
Funding (295)
Gene therapy (151)
GLP-1 (604)
Government (4586)
Healthcare (19727)
Infectious disease (2724)
Inflammatory bowel disease (106)
Interviews (316)
IPO (16627)
Job creations (4037)
Job search strategy (1494)
Layoffs (425)
Legal (8401)
Lung cancer (161)
Manufacturing (153)
Medical device (14137)
Medtech (14142)
Mergers & acquisitions (19849)
Metabolic disorders (382)
Neuroscience (1516)
NextGen Class of 2024 (6894)
Non-profit (4721)
Northern California (1197)
Obesity (230)
Opinion (190)
Patents (95)
People (58937)
Phase I (20389)
Phase II (28907)
Phase III (21641)
Pipeline (208)
Postmarket research (2731)
Preclinical (8708)
Radiopharmaceuticals (244)
Rare diseases (184)
Real estate (6285)
Regulatory (22835)
Research institute (2469)
Resumes & cover letters (359)
Southern California (1082)
Startups (3815)
United States (11797)
Vaccines (573)
Weight loss (179)
Date
Today (89)
Last 7 days (742)
Last 30 days (2762)
Last 365 days (36552)
2024 (30972)
2023 (41144)
2022 (52382)
2021 (57103)
2020 (55916)
2019 (48798)
2018 (36939)
2017 (33748)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (789)
Arizona (194)
Asia (40147)
Australia (6607)
California (2717)
Canada (1169)
China (212)
Colorado (124)
Connecticut (127)
Europe (86781)
Florida (390)
Georgia (106)
Illinois (333)
Indiana (180)
Kansas (98)
Maryland (537)
Massachusetts (2228)
Michigan (145)
Minnesota (256)
New Jersey (828)
New York (838)
North Carolina (713)
Northern California (1197)
Ohio (125)
Pennsylvania (743)
South America (1180)
Southern California (1082)
Texas (388)
Utah (81)
Washington State (328)
720,439 Results for "microbot medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
Microbot Medical Inc. announces that it has received the U.S. Food and Drug Administration’s approval to proceed with its pivotal human clinical trial as part of its Investigational Device Exemption application for its LIBERTY® Endovascular Robotic Surgical System.
June 3, 2024
·
3 min read
Genetown
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Microbot Medical Inc. announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of the Company’s common stock at a purchase price of $1.50 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules.
June 3, 2024
·
5 min read
Genetown
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Microbot Medical Inc. announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 1,566,669 shares of the Company’s common stock at a purchase price of $1.50 per share of common stock.
June 4, 2024
·
5 min read
Genetown
Microbot Medical Announces Brigham and Women’s Hospital as a Site for its Pivotal Human Clinical TrialThe Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was delivered
Microbot Medical Inc. announces that Brigham and Women’s Hospital, a leading academic medical center located in Boston, Massachusetts, will participate as a clinical trial site for the pivotal human clinical trial as part of its Investigational Device Exemption application for its LIBERTY® Endovascular Robotic Surgical System.
June 17, 2024
·
3 min read
Business
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
Microbot Medical Inc., developer of the innovative LIBERTY® Endovascular Robotic Surgical System, reports that the first phase of the previously announced collaboration with Corewell Health has been completed, which demonstrated the LIBERTY® System’s technical capabilities and outlines potential future applications in a range of endovascular interventions.
April 29, 2024
·
3 min read
Press Releases
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
August 13, 2024
·
4 min read
FDA
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
Microbot Medical Inc., developer of the LIBERTY® Endovascular Robotic Surgical System, announced that it has filed an Investigational Device Exemption application with the US Food and Drug Administration.
February 5, 2024
·
3 min read
Press Releases
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
September 17, 2024
·
3 min read
Press Releases
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
October 15, 2024
·
4 min read
Press Releases
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
September 30, 2024
·
4 min read
1 of 72,044
Next